SIEGALL CLAY B bought IMNM
July 29, 2025 · Form 4 insider transaction
SIEGALL CLAY B bought 800,000 shares of Immunome, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
800,000
Price
$0.00
Total value
N/A
InsiderSIEGALL CLAY B
RoleOfficer, Director
CompanyImmunome, Inc. (IMNM)
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJuly 29, 2025
Filing dateJuly 31, 2025
Shares owned after800,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.